APRE
Price
$0.54
Change
-$0.02 (-3.57%)
Updated
Oct 22 closing price
Capitalization
6.82M
20 days until earnings call
Intraday BUY SELL Signals
STTK
Price
$5.60
Change
+$0.02 (+0.36%)
Updated
Oct 22 closing price
Capitalization
562.03M
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APRE vs STTK

APRE vs STTK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APRE vs. STTK commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Hold and STTK is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for APRE with price predictions
Oct 22, 2026

Momentum Indicator for APRE turns negative, indicating new downward trend

APRE saw its Momentum Indicator move below the 0 level on October 01, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 90 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

APRE moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for APRE crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APRE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for APRE entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where APRE's RSI Indicator exited the oversold zone, 43 of 52 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

APRE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 41 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.177) is normal, around the industry mean (2.973). P/E Ratio (-0.576) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. APRE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APRE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for STTK with price predictions
Oct 22, 2026

STTK in downward trend: price expected to drop as it breaks its higher Bollinger Band on September 30, 2026

STTK broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 37 of the 40 cases the stock fell afterwards. This puts the odds of success at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STTK as a result. In 85 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for STTK turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 39 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

The Aroon Indicator for STTK entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where STTK's RSI Oscillator exited the oversold zone, 26 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 57 cases where STTK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

Following a +7.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where STTK advanced for three days, in 223 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 19 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.662) is normal, around the industry mean (2.973). P/E Ratio (-12.727) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (625.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. STTK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
APRE vs STTK: Fundamental Ratings
APRE
STTK
OUTLOOK RATING
1..100
5483
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
8442
P/E GROWTH RATING
1..100
2122
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STTK's Valuation (19) in the null industry is in the same range as APRE (41). This means that STTK’s stock grew similarly to APRE’s over the last 12 months.

STTK's Profit vs Risk Rating (100) in the null industry is in the same range as APRE (100). This means that STTK’s stock grew similarly to APRE’s over the last 12 months.

STTK's SMR Rating (97) in the null industry is in the same range as APRE (98). This means that STTK’s stock grew similarly to APRE’s over the last 12 months.

STTK's Price Growth Rating (42) in the null industry is somewhat better than the same rating for APRE (84). This means that STTK’s stock grew somewhat faster than APRE’s over the last 12 months.

APRE's P/E Growth Rating (21) in the null industry is in the same range as STTK (22). This means that APRE’s stock grew similarly to STTK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APRESTTK
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (APRE: $0.56 vs. STTK: $5.58)
Brand notoriety: APRE and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 19% vs. STTK: 97%
Market capitalization -- APRE: $6.82M vs. STTK: $562.03M
APRE [@Biotechnology] is valued at $6.82M. STTK’s [@Biotechnology] market capitalization is $562.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 1 FA rating(s) are green while STTK’s FA Score has 2 green FA rating(s).

  • APRE’s FA Score: 1 green, 4 red.
  • STTK’s FA Score: 2 green, 3 red.
According to our system of comparison, STTK is a better buy in the long-term than APRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 3 TA indicator(s) are bullish while STTK’s TA Score has 3 bullish TA indicator(s).

  • APRE’s TA Score: 3 bullish, 5 bearish.
  • STTK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both APRE and STTK are a bad buy in the short-term.

Price Growth

APRE (@Biotechnology) experienced а -3.89% price change this week, while STTK (@Biotechnology) price change was +4.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

APRE is expected to report earnings on Nov 11, 2026.

STTK is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
APRE
Daily Signal:
Gain/Loss:
STTK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

APRE and

Correlation & Price change

A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APRE
1D Price
Change %
APRE100%
-3.34%
ATOS - APRE
32%
Poorly correlated
+7.51%
WVE - APRE
28%
Poorly correlated
-0.59%
NTLA - APRE
28%
Poorly correlated
-4.21%
MBRX - APRE
27%
Poorly correlated
-6.66%
STTK - APRE
27%
Poorly correlated
+0.36%
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with GHRS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then GHRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
+0.36%
GHRS - STTK
43%
Loosely correlated
-2.17%
SLDB - STTK
41%
Loosely correlated
-3.43%
CELC - STTK
40%
Loosely correlated
+6.51%
XNCR - STTK
39%
Loosely correlated
+2.70%
WHWK - STTK
39%
Loosely correlated
-1.07%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MPLT8.250.09
+1.10%
MapLight Therapeutics Inc.
AGM201.421.95
+0.98%
Federal Agricultural Mortgage Corp
NYT69.420.56
+0.81%
New York Times Co
SRL4.58-0.05
-1.08%
Scully Royalty Ltd
IPDN2.53-0.09
-3.44%
Professional Diversity Network Inc